Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 1

I4. New vaccines (formerly L3)

Session: Innovations and Advancements in Vaccines

96 - Relative Vaccine Effectiveness Against Influenza-Related and Any Respiratory-Related Hospital Encounter During the 2019/20 High Influenza Activity Period: A Comprehensive Real-World Analysis to Compare Quadrivalent Cell-based and Egg-based Influenza Vaccines

On Demand
Participants should be aware of the following financial/non-financial relationships:
Victoria Divino, PhD: Seqirus (Consultant)
Maarten Postma, Dr.: Seqirus (Consultant)
Stephen I. Pelton, MD: Seqirus (Consultant)
Joaquin F. Mould-Quevedo, PhD: Seqirus (Employee)
Ruthwik Anupindi, PhD: Seqirus (Consultant)
Mitchell DeKoven, PhD: Seqirus (Consultant)
Myron J. Levin, MD: GSK group of companies (Employee, Research Grant or Support)

    Co-Author(s)

  • VD

    Victoria Divino, PhD

    Associate Principal
    IQVIA
    Falls Church, Virginia, United States

    Seqirus (Consultant)

  • MP

    Maarten Postma, Dr.

    Professor in Global Health Economics & Pharmacoeconomics
    University of Groningen
    Groningen, Groningen, Netherlands

    Seqirus (Consultant)

  • SP

    Stephen I. Pelton, MD

    Pediatric I D physician
    Boston Medical Center
    Boston, Massachusetts, United States

    Seqirus (Consultant)

    • Presenting Author(s)

  • Joaquin F. Mould-Quevedo, PhD

    Global Pricing and Health Economics Director
    Seqirus USA Inc.
    Summit, New Jersey, United States

    Seqirus (Employee)

    Slides Slides and Audio

    • Co-Author(s)

  • RA

    Ruthwik Anupindi, PhD

    Senior Consultant
    IQVIA
    Falls Church, Virginia, United States

    Seqirus (Consultant)

  • MD

    Mitchell DeKoven, PhD

    Senior Principal
    IQVIA
    Falls Church, Virginia, United States

    Seqirus (Consultant)

  • ML

    Myron J. Levin, MD

    Professor
    University of Colorado Anschutz Medical Campus
    Aurora, CO, United States

    GSK group of companies (Employee, Research Grant or Support)